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C E L L U L A R  N E U R O S C I E N C E
Three-dimensional chromatin interactions remain 
stable upon CAG/CTG repeat expansion
Gustavo A. Ruiz Buendía1, Marion Leleu2,3, Flavia Marzetta3, Ludovica Vanzan4, Jennifer Y. Tan5, 
Victor Ythier4, Emma L. Randall6, Ana C. Marques5, Tuncay Baubec7, Rabih Murr4,8, 
Ioannis Xenarios1, Vincent Dion6*
Expanded CAG/CTG repeats underlie 13 neurological disorders, including myotonic dystrophy type 1 (DM1) and 
Huntington’s disease (HD). Upon expansion, disease loci acquire heterochromatic characteristics, which may pro-
voke changes to chromatin conformation and thereby affect both gene expression and repeat instability. Here, 
we tested this hypothesis by performing 4C sequencing at the DMPK and HTT loci from DM1 and HD–derived cells. 
We find that allele sizes ranging from 15 to 1700 repeats displayed similar chromatin interaction profiles. This was 
true for both loci and for alleles with different DNA methylation levels and CTCF binding. Moreover, the ectopic in-
sertion of an expanded CAG repeat tract did not change the conformation of the surrounding chromatin. We con-
clude that CAG/CTG repeat expansions are not enough to alter chromatin conformation in cis. Therefore, it is unlikely 
that changes in chromatin interactions drive repeat instability or changes in gene expression in these disorders.
INTRODUCTION
The genome is organized into hierarchical chromatin contact domains 
(1). This three-dimensional (3D) organization of chromatin in the 
nucleus has a profound impact on transcription, DNA replication, 
recombination, and repair (1, 2). For instance, heterochromatic and 
euchromatic loci are spatially separated and display distinct 3D 
chromatin interactions as gleaned by microscopy and chromosome 
conformation capture (3C)–based experiments (2, 3). However, how 
this higher-order chromatin structure impinges on biological func-
tions, what determines chromatin domain boundaries, and how it 
contributes to disease is unclear (4). Expanded CAG/CTG repeat 
loci are ideal to address these questions because they are disease- 
associated loci with changes in local chromatin structure, transcriptional 
output, and genetic instability (5).
CAG/CTG repeats underlie 13 different neurological and neuro-
muscular disorders including myotonic dystrophy type 1 (DM1) and 
Huntington’s disease (HD). They are part of a larger group of 
diseases caused by the expansion of short tandem repeats (STRs) (6). 
Disease-associated STRs (daSTRs) are genetically unstable, especially 
once they surpass a critical threshold of about 35 to 50 repeat units. 
Their expansion is also associated with extensive chromatin remodel-
ing of the expanded loci (5, 7). Two examples of diseases that are 
accompanied by extensive changes in chromatin marks are fragile X 
syndrome (FXS), caused by the expansion of CGG repeats in the 
FMR1 gene located on the X chromosome (8–10), and Friedreich’s 
ataxia (FRDA), caused by a homozygous GAA repeat expansion in 
the first intron of the FXN gene (11). In the case of FXS, expansions 
beyond 200 CGGs are associated with promoter silencing in cis. 
This locus accumulates high levels of heterochromatic marks including 
CpG methylation, H4K20me3, H3K9me2/3, and H3K27me3 while 
losing euchromatin-associated marks such as H3 and H4 acetylation 
as well as H3K4me2 (12–16). Similar chromatin remodeling occurs 
at the FXN locus in FRDA patient tissues where expanded FXN 
alleles display increased DNA methylation, H3K9me2/3, H3K27me3, 
HP1 recruitment, and a loss of CCCTC-binding factor (CTCF) 
binding at sites flanking the expanded GAA repeats (17–21).
The shift from a euchromatic to a heterochromatic state upon 
daSTR expansion has led to the hypothesis that there is a concurrent 
change in the higher-order chromatin conformation of the surround-
ing genomic region. 3C-based experiments revealed alterations in 
3D chromatin interactions surrounding expanded GAA and CGG 
repeats in patient-derived lymphoblastoid cell lines (LCLs) (13, 17, 22). 
In FRDA, a 3C anchor in exon 1 of FXN showed significantly higher 
interactions with genomic sites up to 39 kb upstream and 45 kb 
downstream of the GAA repeats in FRDA patient-derived LCLs 
compared to unaffected cells (17). In FXS patient postmortem brain 
tissue, fibroblasts, and LCLs, CGG repeat expansions were associated 
with the disruption of a topologically associating domain (TAD) 
boundary near the FMR1 gene, decreased interactions near the repeat 
tract, and increased chromatin interactions within the upstream 
chromatin domain (13, 22). Furthermore, daSTRs were found pre-
dominantly at TAD and sub-TAD boundaries enriched in CpG 
islands, suggesting more generally that daSTR expansions may disrupt 
TADs (22). Thus, it was speculated that altered chromatin conform-
ation near expanded daSTR loci might contribute to repeat instability, 
transcriptional misregulation in cis, and ultimately to disease pro-
gression (13, 17, 22).
Two critical unknowns in this model are whether changes in 
higher-order chromatin structure are confined to CGG and GAA 
repeats or if this is general to daSTRs and whether changes in chromatin 
structure cause alterations in gene expression and repeat instability. 
The latter question is especially appealing in the context of the 
expanded CTG repeats in the 3′ untranslated region of the DMPK 
gene in DM1. Similar to FMR1 and FXN, this locus undergoes 
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heterochromatinization upon repeat expansion. The changes in 
local chromatin marks observed at the DMPK locus include the loss 
of CTCF binding, loss of a DNase I hypersensitive site, an increase 
in DNA and H3K9 methylation, as well as a loss of histone acetyla-
tion around the repeat tract (23–27). Moreover, the ectopic intro-
duction of an expanded CAG repeat locus in budding yeast was 
sufficient to relocate the locus to the nuclear periphery in S phase 
cells, leading to changes in repeat size (28). Expanded CAG/CTG 
repeats cause most daSTR disorders. Together, these observations 
prompted us to test the hypothesis that chromatin conform ation is 
altered at expanded CAG/CTG repeat loci. We used 4C sequenc-
ing (4C-seq) to determine the 3D chromatin interactions estab-
lished around the FMR1, HTT, and DMPK loci in unaffected and 
FXS, HD, and DM1 patient LCLs. We also analyzed the chromatin in-
teractions of an ectopic CAG repeat expansion in human embryonic 
kidney (HEK) 293–derived cells. We confirmed the alteration of 
chromatin interactions in a FXS patient cell line with ~935 CGG 
repeats. However, we found no evidence of changes in chromatin 
interactions caused by expanded CAG/CTG repeats in HD or DM1 
patient cells. This suggests that 3D conformational changes are 
unlikely to underlie the alterations in transcriptional output or genetic 
instability of disease-associated expanded CAG/CTG repeat loci. 
This was consistent in different cell types, genetic backgrounds, and 
in the presence of specific heterochromatic marks. Therefore, we 
conclude that changes in higher-order chromatin conformation are 
unlikely to contribute to the pathogenesis of expanded CAG/CTG 
repeat disorders.
RESULTS
Chromatin conformation changes upon CGG repeat 
expansion at the FMR1 locus
To determine the chromatin conformation of expanded daSTRs, we 
used 4C-seq (29) to maximize the resolution of chromatin inter-
actions at these loci. This method allows a high sensitivity to small 
changes in conformation that may be missed by other 3C-based 
methods. To test our approach, we sought to reproduce the obser-
vation of changes in chromatin conformation at the FMR1 locus 
upon CGG repeat expansion with 4C-seq (13, 22). We used two 
LCLs that were used in a previous study (22), one derived from a 
patient with FXS with ~935 CGG repeats (GM09237) and the other 
derived from their unaffected male sibling (GM09236), here referred 
to as FXS and UN-A, respectively (Fig. 1A and table S1).
To determine the chromatin interactions established at the 
FMR1 locus, we used a 4C viewpoint located 1 kb upstream of the 
CGG repeats and another at 195 kb upstream (table S2). We also 
determined the chromatin conformation of an unrelated locus, 
ACTA1 on chromosome 1, to control for a potential effect of FXS on 
genome-wide chromatin conformation. We obtained three replicates 
of each 4C viewpoint and found that replicates from the same cell 
line showed good correlation in 4C fragments with at least 20 mapped 
reads (fig. S1, A to C). We identified interaction peaks and broader 
high-interacting regions that contacted the 4C viewpoints at fre-
quencies higher than expected given their linear distance away from 
the viewpoints. These significant interactions were determined using 
two 4C-seq data analysis packages: FourCSeq (30) and 4C-ker (31). 
We then compared the chromatin interaction profiles between the 
UN-A and FXS cell lines to identify regions of significant differential 
interaction frequency (called differential interactions; see Materials 
and Methods) (Fig. 1, B and C). As expected from 5C interaction 
maps (22), we found significant differences in chromatin interactions 
near the CGG repeats of FMR1, where the FXS patient cells showed 
decreased interactions encompassing the expanded repeats and the 
upstream regions of FMR1 (Fig. 1B). By contrast, we did not find 
significant changes in chromatin interactions with a viewpoint 
located 195 kb upstream of FMR1, located within the upstream 
TAD (fig. S2). In addition, at the ACTA1 locus, we found that the 
interaction profiles were similar between the two cell lines within a 
2-Mb region around the viewpoint (Fig. 1C). This suggests that 
CGG repeat expansion alters chromatin interactions only in the 
vicinity of the FMR1 locus. Thus, we confirmed previous observations 
made with 5C and we concluded that changes in chromatin conform-
ation caused by daSTRs could readily be detected with 4C-seq.
Chromatin conformation is stable upon CAG repeat 
expansion at the HTT locus
To assess whether chromatin interactions change upon CAG repeat 
expansion at the HTT locus, we used three HD patient–derived 
LCLs: GM02164 (44 and 56 CAGs), GM03620 (18 and 70 CAGs), and 
GM14044 (19 and 750 CAGs), referred to as HD-A, HD-B, and HD-C, 
respectively. We compared them to two cell lines from unaffected 
individuals (GM04604 and GM02180, UN-B and UN-C, respectively). 
Their family relationships and their repeat sizes are shown in Fig. 2A 
and table S1.
To determine the chromatin conformation of the HTT locus, we 
used two 4C viewpoints within the HTT gene body—1 kb (HTT_d1) 
and 85 kb (HTT_d85) downstream of the CAG repeats in unaffected 
and HD patient cells (table S2). We also assessed the chromatin 
conformation of the unrelated ACTA1 gene. Replicates from the 
same cell lines showed good correlation in fragments with more 
than 20 mapped reads (fig. S1, D to F). Compared to the UN-B and 
UN-C cells, we found that the chromatin interaction profiles were 
similar within a 2-Mb region around the HTT viewpoints in all 
three HD patient LCLs (Fig. 2B and fig. S4). The ACTA1 viewpoint 
also produced indistinguishable interaction profiles between un-
affected and HD patient cells (Fig. 2C). We identified a few small 
regions displaying differential interactions, but they were mainly 
outside regions of significant interactions (Fig. 2, B and C). In addition, 
most regions of differential interactions were not exclusive to HD 
patient cells, as they were also found in comparisons between the 
two unaffected cell lines (Fig. 2, B and C). This suggests that the 
minor changes in chromatin interaction frequencies are due to factors 
other than the presence of expanded CAG repeats in HTT, for 
example, a difference in genetic background. Together, our results 
show that expanded CAG repeats at the HTT locus do not cause 
significant alterations of its chromatin conformation.
To determine the relationship, if any, of chromatin conformation 
at the HTT locus with gene expression in cis, we performed RNA 
sequencing (RNA-seq) experiments with the same unaffected and 
HD patient cells. Differential gene expression analysis between the 
HD and unaffected LCLs identified 1183 significantly up-regulated 
and 1307 significantly down-regulated genes (log2 fold change > 0.5, 
adjusted P < 0.05; fig. S5A and table S3). Within a 2-Mb region centered 
around HTT, we identified 4 genes of 25 that showed significant 
differential expression between the HD patient and the unaffected 
cell lines (fig. S5A). This proportion was not statistically different 
from the proportion of differentially expressed genes in a 2-Mb re-
gion around ACTA1 (Fisher’s exact test, P = 0.12). Given that the 
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chromatin interactions did not significantly change between the HD 
and unaffected cell lines in the HTT region, our data suggest that 
changes in gene expression in cis occur independently of the chromatin 
conformation of expanded HTT alleles in HD patient cells.
Chromatin conformation is stable upon CTG repeat 
expansion at the DMPK locus
Repeat expansion at the HTT locus is not known to be associated 
with changes in local histone modifications and chromatin accessi-
bility, which might cause changes in chromatin conformation. To 
determine whether an expanded CTG repeat locus with local heter-
ochromatic chromatin marks is associated with altered 3D chroma-
tin conformation, we used the unaffected cell lines UN-B and UN-C 
and two DM1 patient–derived LCLs (GM06077 and GM04648, re-
ferred to as DM1-A and DM1-B, respectively). The DM1-A cell line 
harbored one expanded DMPK allele with 1700 CTGs and the 
DM1-B cell line, 1000 CTGs (Fig. 3A and table S1). Using bisulfite 
sequencing, we found that DM1-A cells harbored increased CpG 
methylation levels at two CTCF binding sites flanking the CTG re-
peats (fig. S6, A and B). To assess the CTCF occupancy levels at the 
two flanking sites, we performed CTCF chromatin immunoprecipi-
tation (ChIP) followed by quantitative PCR (qPCR) and found that 
CTCF binding was reduced at both sites in the DM1-A cell line 
(fig. S6C). In DM1-B cells, we observed normal methylation levels 
at both CTCF binding sites (fig. S6B) and slightly reduced CTCF 
occupancy in the downstream site (fig. S6C). Thus, DM1-A cells 
displayed molecular signatures of congenital DM1 (32), whereas 
DM1-B cells had characteristics of adult-onset DM1 (table S1).
To determine whether expanded CTG repeats affect chromatin 
conformation at the DMPK locus, we performed 4C-seq with the 
unaffected and DM1 cell lines using four different 4C viewpoints at 
distinct distances away from the CTG repeats of DMPK (Fig. 3B, fig. S7, 
and table S2). Replicates from the same cell lines also showed good 
correlation for 4C fragments with at least 20 reads (fig. S1, G to K). 
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Fig. 1. Chromatin interactions of the FMR1 locus in unaffected and FXS patient cells. (A) Pedigree of the unaffected and FXS patient cell lines used. (B) 4C-seq 
chromatin interaction profiles (average of triplicate smoothed and normalized counts) from the FMR1_u1 viewpoint (1 kb upstream of the CGG repeats of FMR1, gray 
central triangle) in one unaffected (UN-A) and one FXS patient cell lines (FXS). The top blue arrow represents the FMR1 gene and the left-side triangle represents the location 
of the FMR1_u195 4C viewpoint. The interaction profiles for the FMR1_u195 viewpoint (195 kb upstream of the CGG repeats of FMR1) can be found in fig. S2. (C) 4C-seq 
chromatin interaction profiles (average of triplicate smoothed and normalized counts) from the ACTA1 viewpoint (central purple triangle). The top blue bar represents the 
ACTA1 gene. For (B) and (C), high-interacting regions were called using 4C-ker and significant interactions were called using FourCSeq. Regions of differential interactions 
compared to UN-A are marked with black bars below each 4C-seq track and labeled as “diff. int.”. 4C vps, viewpoints used for 4C-seq.
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Fig. 2. Chromatin interactions of the HTT locus in unaffected and HD patient cells. (A) Pedigree of the unaffected and HD patient cell lines used. (B) 4C-seq chromatin 
interaction profiles (average of triplicate smoothed and normalized counts) from the HTT_d1 viewpoint (1 kb downstream of the CAG repeats of HTT, red central triangle) 
in two unaffected (UN-B and UN-C) and three HD patient cell lines (HD-A, HD-B, and HD-C). The top blue arrow represents the HTT gene and the triangles represent the 
location of both HTT viewpoints. The interaction profiles for the HTT_d85 viewpoint (85 kb downstream of the CAG repeats) can be found in fig. S4. (C) 4C-seq chromatin 
interaction profiles (average of triplicate smoothed and normalized counts) from the ACTA1 viewpoint (central purple triangle). The top blue bar represents the ACTA1 
gene. For (B) and (C), high-interacting regions were called using 4C-ker and significant interactions were called using FourCSeq. Regions of differential interactions com-
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Fig. 3. Chromatin interactions of the DMPK locus in unaffected and DM1 patient cells. (A) Pedigree of the unaffected and DM1 patient cell lines used. (B) 4C-seq chromatin 
interaction profiles (average of triplicate smoothed and normalized counts) from the DMPK_d11 viewpoint (11 kb downstream of the CTG repeats of DMPK, yellow triangle) in 
two unaffected (UN-B and UN-C) and two DM1 patient cell lines (DM1-A and DM1-B). The top blue arrow represents the DMPK gene and the triangles represent the location of 
the four DMPK viewpoints. The profiles for the three other viewpoints can be found in fig. S7. (C) 4C-seq chromatin interaction profiles (average of triplicate smoothed 
and normalized counts) from the ACTA1 viewpoint (central purple triangle) in two unaffected and two DM1 patient cell lines. The top blue bar represents the ACTA1 gene. 
For (B) and (C), high-interacting regions were called using 4C-ker and significant interactions were called using FourCSeq. Regions of differential interactions compared to 
UN-B are marked with black bars below each 4C-seq track and labeled as “diff. int.”. (D) Circos plot of the significant interactions called with FourCSeq (nominal P < 0.05) from 
four different viewpoints surrounding the CTG repeats of DMPK in the unaffected and DM1 cell lines (left and right, respectively) (DMPK_u65 in blue, DMPK_u16 in green, 
DMPK_d11 in yellow, and DMPK_d73 in orange; 65 kb upstream, 16 kb upstream, 11 kb downstream, and 73 kb downstream, respectively). (E) Circos plot of the significant 
interactions called with FourCSeq (nominal P < 0.05) from the control ACTA1 viewpoint in unaffected and DM1 cell lines (left and right, respectively).
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Similar to the HD samples, we observed notably similar chromatin 
interaction profiles between the unaffected and DM1 samples for all 
four viewpoints in the DMPK region (Fig. 3B and fig. S7). As ex-
pected, the ACTA1 viewpoint also showed interaction profiles in-
distinguishable between unaffected and DM1 cell lines (Fig. 3C). As 
with the HTT viewpoints, none of the DMPK or ACTA1 viewpoints 
in DM1 patient cells had significant interactions that were also called 
as regions of differential interaction (Fig. 3, B and C). Furthermore, 
we found that the significant interactions identified for all four 
DMPK viewpoints and the ACTA1 viewpoint in unaffected and 
DM1 patient cells were largely the same (Fig. 3, D and E). Thus, we 
found no evidence of large-scale changes in chromatin conformation 
at the DMPK locus driven by CTG expansions.
We confirmed by RNA-seq that transcriptional misregulation in 
DM1 patient cells occurs genome-wide as well as within a 2-Mb 
region centered around DMPK (fig. S5B and table S4). Similar to 
our observation in HD individuals, changes in gene expression in 
cis occurred independently of the 3D conformation of the DMPK 
locus in DM1 patient cells.
To determine the extent of CTCF occupancy alterations in the 
DM1 patient cells, we performed ChIP sequencing (ChIP-seq) (fig. S8). 
At the genome-wide level, comparing DM1-A to UN-B cells, we 
found 1951 sites where CTCF binding changed significantly [false 
discovery rate (FDR) < 5%]. DM1-B cells harbored 833 sites with 
significantly altered CTCF occupancy genome-wide compared to 
UN-B cells (FDR < 5%). However, in a 2-Mb region centered around 
DMPK, only 4 of 131 (3%) CTCF binding peaks showed significant 
differential occupancy in DM1-A patient cells compared to the 
UN-B cell line (fig. S8). There were no binding sites with significant 
differences in CTCF occupancy out of 135 peaks in that same region 
when comparing the UN-B and DM1-B cell lines (fig. S8). There-
fore, we concluded that there were no large-scale changes in CTCF 
occupancy in the DM1 patient LCLs either genome-wide or within 
a 2-Mb region around the expanded CTG repeats, which is consistent 
with the absence of changes in chromatin conformation observed 
by 4C-seq in these cells.
Lack of allelic bias in chromatin interactions at expanded 
CAG/CTG repeats
DM1 and HD are both dominantly inherited disorders wherein 
affected individuals are heterozygous for the expanded allele. Thus, 
one potential caveat in our data was that the presence of a normal- 
length allele could mask changes in the 3D chromatin interactions 
made by the expanded allele. To evaluate this possibility, we took 
advantage of the presence of at least one parental cell line for the 
DM1-A and HD-B individuals in our dataset (Figs. 2A and 3A) and 
identified biallelic single-nucleotide polymorphisms (SNPs) in the 
contacted 4C fragments from these samples. We selected a subset of 
the SNPs that could be assigned unambiguously to either the ex-
panded or the normal allele within 1 Mb of the 4C viewpoints 
(see Materials and Methods). We reasoned that if chromatin contacts 
were established without a systematic bias for either the expanded 
or normal allele in DM1 and HD patient cells, then the proportion 
of 4C fragments in which the expanded chromosome had more 
reads than the normal-length one would be close to 50%. There-
fore, we analyzed the sequencing coverage of the 4C-seq data at 
the biallelic SNP positions and found that the viewpoints did not 
establish preferential contacts with a single chromosome in either 
the DM1-A or HD-B patient cell lines (Table 1). These results are 
consistent with the conclusion that chromatin interactions at both 
disease loci do not show allelic bias. Together, these results corrobo-
rate the conclusion that expanded CAG/CTG repeats do not signifi-
cantly alter the chromatin interactions at two expanded CAG/CTG 
repeat loci.
Chromatin conformation is stable at an ectopic  
CAG repeat locus
It remained possible that differences in genetic background in the 
LCLs that we analyzed could have had a confounding effect on the 
chromatin interactions made at expanded CAG/CTG repeat loci. 
To test this, we compared the chromatin interactions of a hemizygous 
ectopic locus with either 15 [GFP(CAG)15] or 270 CAGs [GFP(CAG)270] 
in isogenic cell lines. We obtained two clonal populations of HEK293 
T-Rex Flp-In cells that contain a single, stably integrated construct 
containing CAG repeats within the intron of a green fluorescent 
protein (GFP) mini-gene controlled by a doxycycline-inducible 
promoter (33). Using targeted locus amplification (34), we mapped 
its insertion site to the p-arm of chromosome 12, 1.2 Mb from the 
telomere (Fig. 4A). We performed 4C-seq in both cell lines with a 
viewpoint located 1 kb upstream of the CAG repeats. The chromatin 
interaction profiles of this ectopic CAG repeat locus were similar 
between the 15 and 270 CAG repeat cells, with few regions of differ-
ential interactions overlapping with high-interacting regions iden-
tified with 4C-ker (Fig. 4B). Thus, we concluded that expanded 
CAG repeats cause few changes to the chromatin conformation of 
an ectopic locus in isogenic cells.
Table 1. Allele-specific interactions in 4C-seq data.  
Cell line Disease Genomic region* Total no. of samples
No. of samples 
with more normal 
chromosome 
reads
No. of samples 
with more 
expanded 
chromosome 
reads
P†
DM1-A DM1 ACTA1 5 1 4 0.38
DMPK 41‡ 26 15 0.12
HD-B HD ACTA1 12 7 5 0.77
HTT 43 20 23 0.76
 *One-megabase region around the 3′ end of DMPK, 5′ end of HTT, or the ACTA1 4C-seq viewpoint.   †P value of an exact binomial test.   ‡One sample had 
the same number of reads in both alleles; thus, it was not included.
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Some studies suggest that transcription can help define chromatin 
domain boundaries (35). To determine whether transcription through 
expanded CAG repeats could lead to changes in chromosome con-
formation, we induced transcription at this locus by culturing the 
GFP(CAG)15 and GFP(CAG)270 cells with doxycycline for 5 days 
and subsequently performed 4C-seq using the same GFP viewpoint. 
We observed that 2 of 17 regions of differential interactions over-
lapped fully or in part with high-interacting regions over a 2-Mb 
region (Fig. 4C). By contrast, we identified no significant interactions 
in this region using FourCSeq. Together, these results suggest that 
an ectopic expanded CAG repeat tract is not enough to significantly 
alter the chromosome conformation of this locus, regardless of its 
transcriptional status.
DISCUSSION
Here, we showed that chromatin interactions remain stable at ex-
panded CAG/CTG repeat loci. This was true for two disease loci (HTT 
and DMPK) and one ectopic locus in two different cell types. Our 
findings are supported by allele-specific analysis of 4C-seq chromatin 
interactions. Furthermore, increased CpG methylation and CTCF 
binding alterations at four sites in a 2-Mb region around DMPK did 
not affect the chromosome conformation of this locus in the DM1-A 
patient cells. This is especially relevant because CTCF is a key archi-
tectural protein involved in the demarcation of TAD and sub-TAD 
boundaries (36). In addition, when we inserted a hemizygous trans-
gene with CAG repeats, we found that expanded CAG repeats did 
not induce a significant reorganization of the chromatin contacts 
established at this ectopic repeat locus. These results show that an 
expanded CAG/CTG repeat tract is not sufficient to change chro-
matin conformation in cis.
One possible explanation for why we observed strikingly similar 
chromatin interactions in the expanded CAG/CTG repeat loci tested 
here is that changes in chromatin interactions caused by expanded 
daSTRs only occur in affected cell types, such as cardiomyocytes or 
medium spiny neurons, but not in LCLs. Such a scenario would 
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Fig. 4. Chromatin interactions of an expanded CAG repeat locus in isogenic cells. (A) Diagram of the integration site of the CAG ectopic locus in GFP(CAG)15 and 
GFP(CAG)270 cells. (B) 4C-seq chromatin interaction profiles (average of triplicate smoothed and normalized counts) from the GFP viewpoint in GFP(CAG)15 (top) and GFP(CAG)270 
(bottom) in cells without active transcription of the ectopic CAG locus. Regions of differential interactions compared to GFP(CAG)15 are marked with black bars below the 
GFP(CAG)270 4C-seq track. (C) 4C-seq chromatin interactions from the GFP viewpoint in GFP(CAG)15 (top) and GFP(CAG)270 (bottom) in cells treated with doxycycline for 5 days 
to induce transcription of the ectopic CAG locus. Regions of differential interactions compared to GFP(CAG)15 are marked with black bars below the GFP(CAG)270 4C-seq track.
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require cell type–specific factors to mediate these changes. Here, we 
tested the transcriptional status, DNA methylation levels, and 
CTCF binding in DM1 patient LCLs. We found that these cells dis-
played transcriptional and epigenetic signatures similar to those found 
in heart, liver, cortex, and peripheral blood samples of patients with 
DM1 (23, 32). Thus, cell type–specific differences in chromatin 
conformation are possible but unlikely given the similarity in local 
chromatin modifications between the tissues.
Our findings are in contrast to the effect of expanded CGG and 
GAA repeats on chromosome conformation (13, 17, 22). In FXS 
patient–derived LCLs, fibroblasts, and brain tissue, expanded CGG 
repeats in FMR1 were associated with heterochromatic characteristics, 
decreased CTCF binding, and a disruption of a TAD boundary near 
the expanded repeats (22). The DM1 patient cells used here, espe-
cially the congenital DM1 patient cell line (DM1-A), showed similar 
changes in chromatin modifications to FXS patient cells. And yet, 
these factors did not amount to an alteration of the 3D chromatin 
interactions at the expanded DMPK locus. There are notable dis-
similarities between FXS/FRDA and DM1/HD that could account 
for the difference in the effect of distinct daSTRs on chromosome 
conformation. Apart from the nucleotide composition of the repeat 
tract itself, the disease loci and their flanking sequences are differ-
ent. It is possible that the extent of heterochromatin formation is 
different between distinct expanded repeat loci, thereby eliciting 
different effects on the surrounding 3D chromatin conformation. 
Similarly, how far CpG methylation spreads and how much CTCF 
occupancy is disrupted upon repeat expansion is not fully under-
stood and may account for the differences between the daSTR loci 
examined so far. It seems likely that all these dissimilarities between 
the loci examined so far contribute to the changes, or lack thereof, 
in chromatin conformation upon expansion of daSTRs.
It was speculated that the changes in chromatin conformation 
caused by expanded daSTRs could lead to repeat instability (22). 
CGG repeat expansions beyond 200 units are associated with re-
duced instability, promoter silencing, and 3D chromatin conform-
ation changes (22, 37, 38). By contrast, long GAA repeat tracts are 
more unstable (6, 39), and yet, their chromosome conformation is 
also altered. We found that long CAG/CTG repeats, which are more 
unstable as they expand, are not associated with changes in 3D 
chromatin interactions. Thus, there does not appear to be a general 
functional link between chromatin conformation and repeat insta-
bility across distinct daSTR loci.
Similarly, we found that transcription around the HTT and 
DMPK regions in patients with HD and DM1 is unrelated to the 
chromatin conformation of the expanded repeat loci. Rather, it is 
more likely that the local transcriptional misregulation observed in 
patients is caused by changes in local chromatin marks. Our results 
are in line with recent evidence in Drosophila arguing that genome 
topology is not predictive of genome-wide transcriptional output (40). 
We did not find evidence that supports a common link between 3D 
genome organization and the transcriptional misregulation typical 
of expanded daSTRs. Overall, our data argue that changes in chro-
matin topology are unlikely to underpin the molecular pathology of 
expanded CAG/CTG repeat disorders.
The expanded CAG/CTG repeat loci in DM1 and HD provide 
an endogenous genomic substrate to study the mechanisms necessary 
for the establishment of 3D chromatin domains in daSTRs given the 
involvement of CTCF binding, CpG methylation, and other chro-
matin remodeling events at these loci. In particular, CTCF plays a 
central role in the establishment of chromatin loops and chromatin 
contact domains (36). Our data show that chromatin interactions 
remain stable near the DMPK region despite precise alterations in 
CTCF binding near a chromatin contact domain boundary. This is 
in line with several recent observations wherein interfering with 
CTCF binding at chromatin domain boundaries does not result in a 
reorganization of the underlying 3D topological chromatin structure. 
For example, neither the deletion nor the ectopic insertion of the 
Firre locus, a long noncoding RNA on the X chromosome surrounded 
by 15 CTCF binding sites, was enough to alter the TAD structure of 
the surrounding genomic region in mouse cells (41). Similarly, a 
TAD boundary in the HoxD gene cluster was highly resilient to 
genomic deletions encompassing multiple CTCF binding sites (42). 
Therefore, these results, together with ours, imply a model whereby 
the establishment and maintenance of chromatin conformation is 
dependent on the chromosomal context of a given genomic locus.
MATERIALS AND METHODS
Cell lines
All LCLs were obtained from the Coriell Institute for Medical 
Research Cell Repository. They were grown at 37°C and 5% CO2 in 
RPMI 1640 medium supplemented with 15% fetal bovine serum, 
2 mM l-glutamine, and 1% penicillin-streptomycin. Cells were 
counted and passaged every 3 to 4 days depending on cell density. 
The GFP(CAG)270 and GFP(CAG)15 lines were previously characterized 
(33). They were maintained at 37°C and 5% CO2 in Dulbecco’s 
minimum Eagle’s medium with GlutaMAX, 1% penicillin-streptomycin, 
blasticidine (15 g ml−1), and hygromycin (150 g ml−1). Transcription 
of the GFP mini-gene was activated by culturing GFP(CAG)n cells 
with doxycycline at a final concentration of 2 g ml−1 for 5 days.
Repeat length determination and small-pool PCR
Genomic DNA was isolated from each LCL using the NucleoSpin 
Tissue Kit (Macherey-Nagel). PCR products with the CAG repeats 
from HTT were produced with primers oVIN-1333 and oVIN-1334 
(table S5). PCR products containing the CTG repeats from DMPK 
were amplified with primers oVIN-1252 and oVIN-1251 (table S5). 
For normal-length alleles, several PCRs were set up with MangoTaq 
(Bioline), and the products were gel-extracted and Sanger-sequenced 
with the same primers used for the amplification. For expanded alleles, 
small-pool PCRs were performed on the basis of a previously described 
protocol (43). Briefly, the same primers were used for the amplification 
of expanded DMPK and HTT alleles with 1 ng of genomic DNA per 
PCR. The products were run on an agarose gel and transferred to a 
nylon membrane. An oligo made up of 10 CAGs was used to obtain 
a radioactive probe used for the visualization of the expanded alleles. 
The number of repeats reported here is an estimation of the modal 
number of repeats.
Bisulfite sequencing
Bisulfite sequencing was performed according to a previously described 
method (32). Bisulfite conversion was performed with the EZ DNA 
Methylation Kit (Zymo Research) using the standard protocol. Two 
hundred nanograms of genomic DNA was used for bisulfite conversion 
at 50°C for 12 hours. Bisulfite-converted DNA was desulfonated, 
eluted, and immediately used for nested and heminested PCR 
amplification of the upstream and downstream CTCF binding sites, 
respectively, using previously described primers (32). Fifty nanograms 
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of bisulfite-converted DNA was used for the first PCR, and 3 l of 
the products was used for the second PCR. The final amplicons were 
purified with the NucleoSpin PCR Clean-up Kit (Macherey-Nagel) 
and used for 2 × 250–base pair (bp) paired-end sequencing on Illumina 
MiSeq. The primers used for both rounds of PCR are found in table S5.
Bisulfite sequencing data analysis
Sequencing reads were preprocessed using Trim Galore (github.com/
FelixKrueger/TrimGalore) with the following parameters: -q 
20 --length 20 –paired. Reads were aligned using QuasR (44) to the 
GRCh38 human reference DNA sequences corresponding to the 
amplified PCR products. DNA methylation calls for each CpG were 
extracted using the qMeth() function in QuasR. DNA methylation 
frequencies were calculated as methylated CpG reads / total number 
of reads covering the respective CpG × 100.
CTCF ChIP-qPCR and ChIP-seq
ChIP was performed according to the Diagenode Auto iDeal 
ChIP-qPCR Kit (Diagenode) standard protocol. Samples of 6 × 106 
cells were sonicated using the Diagenode Bioruptor Pico (Diagenode), 
with 10 cycles of 30 s “on” and 30 s “off.” Correct DNA fragmentation 
was verified by agarose gel electrophoresis. Immunoprecipitation 
was performed with 4 × 106 cells using a CTCF antibody (Diagenode) 
and the Diagenode IP-Star Compact Automated System robot 
(Diagenode). Results were analyzed using the StepOnePlus qPCR 
by Applied Biosystems (Thermo Fisher Scientific) with Applied 
Biosystems SYBR Green PCR Master Mix (Thermo Fisher Scientific). 
The primer sequences used for qPCR are listed in table S5. CTCF 
ChIP-seq libraries were prepared in triplicate using the Illumina 
TruSeq ChIP Sample Preparation Kit. We performed 1 × 50-bp single- 
end sequencing with Illumina HiSeq 4000.
CTCF ChIP-seq data analysis
CTCF ChIP-seq reads were demultiplexed with the bcl2fastq2 Illu-
mina software (v 2.20.0). Data analysis was performed according to 
the ENCODE Transcription Factor ChIP-seq processing pipeline 
(phase 3). Demultiplexed reads were aligned to the GRCh38 human 
reference genome (GCA_000001405.15) using bowtie2 (v 2.3.4.3) 
(45). Reads were filtered to remove unmapped reads, reads with no 
primary alignment, multimapped reads, and duplicate reads so that 
only the reads that mapped to the genome once were considered for 
downstream analyses. CTCF peaks were identified using the ChIP-
seq processing pipeline (46). The irreproducible discovery rate (47) 
framework was used to ensure reproducibility between experimental 
replicates. Differentially enriched CTCF peaks were detected with 
DiffBind (48). We used DESeq2 (49) to identify peaks that are statis-
tically differentially bound between sample groups (P < 0.05 and 
FDR < 5%). First, we computed count information for each of the 
peaks in the consensus set. Bedgraph files (representing a normalized 
coverage per base) were created to visualize the tracks.
4C sequencing
4C library preparation was performed on the basis of a previously 
described protocol (29). For each sample, 107 cells were cross-linked in 
2% formaldehyde for 10 min at room temperature and quenched with 
glycine to a final concentration of 0.13 M. Cross-linked samples were 
rinsed once with phosphate-buffered saline and were either used 
immediately or flash-frozen in liquid nitrogen and stored at −80°C 
for later use. Cells were lysed for 15 min on ice in lysis buffer [50 mM 
tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 0.5% NP-40, 1% 
Triton X-100, and 1× protease inhibitors]. The first digestion was 
performed with 200 U of Dpn II (New England Biolabs) and incubating 
for 4 hours at 37°C, then 200 U of Dpn II and overnight incubation 
at 37°C, and lastly 200 U of Dpn II and incubating 4 hours at 
37°C. Dpn II digestion efficiency was assessed by agarose gel electro-
phoresis, and Dpn II was subsequently heat inactivated. The first 
ligation was performed at 16°C overnight with 50 U of T4 DNA 
ligase (Thermo Fisher Scientific) in 7 ml. Ligated samples were 
decross-linked with 30-l Proteinase K (10 mg/ml) at 65°C overnight 
followed by ribonuclease A (RNAse A) treatment and phenol-chloroform 
purification. The second digestion was performed with 50 U of Bfa I 
(New England Biolabs) at 37°C overnight followed by Bfa I heat in-
activation. The second ligation was performed at 16°C overnight 
with 100 U of T4 DNA ligase in 14 ml. The resulting 4C template 
samples were precipitated and purified with the QIAquick PCR 
purification Kit. 4C libraries were generated by amplifying 1-g total 
of purified 4C template using the Expand Long Template PCR Sys-
tem (Roche) with 4C viewpoint primers with Illumina sequenc-
ing adapters that permitted multiplexing (in 50-l PCRs), pooling 
reactions, and purifying the PCR products with AMPure XP beads 
to exclude products less than 130 bp. The 4C viewpoint primer se-
quences are listed in table S5. Single-end sequencing of pooled 
4C libraries was performed on Illumina HiSeq 2500.
4C-seq data analysis
Demultiplexing, trimming, and mapping were performed using the 
BBCF HTSstation (50), according to (51). Reads were trimmed to 
keep the first 40 bp. The 4C fragments surrounding the viewpoints 
(±2.5 kb) were excluded from the rest of the analysis. The demultiplexed 
reads were mapped to the GRCh38 human reference genome using 
bowtie2 (v 2.2) (45). Fragment read counts were obtained using 
FourCSeq (v 1.18.0) (30). The number of mapped reads for each 
sample is found in table S2. For plotting the data, fragment counts 
were normalized (reads per million) and smoothed with a running 
mean (window size = 5 fragments). The smoothed and normalized 
fragment counts were averaged among replicates of the same 4C library 
samples and visualized with gFeatBrowser (www.gfeatbrowser.com). 
Significant chromatin interactions were identified with two 4C-seq 
data analysis packages: FourCSeq (v 1.18.0) (30) and 4C-ker (v 0.0.0.9000) 
(31). For the FourCSeq analysis, we defined significant interactions 
as fragments with a z score equal to or greater than 1.96 and an FDR 
of 0.1, using the following parameters: minCount = 20 and fitFun = 
“distFitMonotone” in the getZScores function; zScoreThresh = 1.96, 
fdrThresh = 0.1 in the addPeaks function. 4C-ker uses a Hidden 
Markov Model that accounts for differences in coverage near 4C 
viewpoints to determine three types of domains: high-interacting, 
low-interacting, and noninteracting domains. For each viewpoint, 
we used k = 5 in the nearBaitAnalysis function and plotted 
the high-interacting regions. The difference between significant 
interactions called with FourCSeq and 4C-ker is expected given 
that FourCSeq usually identifies “peaks” of significantly interacting 
regions whereas 4C-ker identifies regions (52). Differential inter-
actions were identified with the differentialAnalysis function of 
4C-ker, which is based on the DESeq2 (49) framework, using 
default parameters (including a P value threshold of 0.05). The 
UN-B cell line was used as the reference condition for all compari-
sons except for Fig. 1 and fig. S2 where the reference condition was 
the UN-A cell line.
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4C SNP data analysis
We called SNPs from 4C-seq data from the DM1-A and HD-B 
patient–derived LCLs using GATK (v 3.7.0) (53) and samtools/
bcftools (v 1.5 and v 1.4.1, respectively) (54). Biallelic SNPs located 
within a 1-Mb region of the 3′ end of DMPK, the 5′ end of HTT, and 
the ACTA1 4C viewpoint were selected. Among these, only SNPs 
that could unambiguously inform which parental allele they came 
from were retained for downstream analysis. This required a homo-
zygous genotype in at least one of the parental cell lines. We validated 
a subset of these SNPs by isolating genomic DNA from the UN-B, 
UN-C, HD-A, HD-B, and DM1-A cell lines and using it for PCR 
amplification of the genomic region encompassing the variants in 
the parental and offspring LCLs followed by library preparation and 
2 × 250-bp paired-end sequencing was performed with Illumina 
MiSeq. We then analyzed the sequencing coverage at the confirmed 
biallelic SNP positions from the 4C-seq data from DM1-A and HD-B 
patient cell lines. For samples with at least 10 reads per SNP position, 
we counted the number of times the expanded allele had more mapped 
reads than the normal allele. We applied an exact binomial test to 
statistically assess whether the proportion of cases where the expanded 
allele had more reads than the normal allele was significantly differ-
ent to 0.5, which represented the null hypothesis of no allelic bias.
RNA isolation and sequencing
For each sample, RNA from 5 million cells was extracted using the 
NucleoSpin RNA Kit (Macherey-Nagel), and its concentration was 
measured by NanoDrop (NanoPhotometer NP80, Implen). RNA quality 
was assessed on a Fragment Analyzer (Agilent Technologies), and all 
of the RNA samples had an RNA quality number between 8.7 and 10. 
RNA-seq libraries were prepared using 500 ng of total RNA and the 
Illumina TruSeq Stranded Total RNA Library Prep Kit with Ribo- Zero 
Gold (Illumina) according to the manufacturer’s protocol. Multi-
plexed samples were pooled in equimolar amounts, and 2 × 100-bp 
paired-end sequencing was performed on Illumina HiSeq 2500.
RNA-seq data analysis
RNA-seq reads were demultiplexed using the bcl2fastq Illumina 
software (v 2.20.0). Purity-filtered reads were trimmed with Cutadapt 
(v 1.3) (55) and filtered for low complexity with seq_crumbs (v 0.1.8). 
Reads were aligned against the GRCh38 human transcriptome 
(GRCh38.82) using STAR (v 2.4.2a) (56). Genes differentially ex-
pressed in HD and DM1 LCLs compared to unaffected LCLs were 
determined using DESeq2 (v 1.20.0) (49) while accounting for batch 
effects including cell passage number, collection date, and sequencing 
runs. P values were adjusted using the Benjamini-Hochberg multiple 
testing correction. Significantly differentially expressed genes were 
defined as those with adjusted P values less than 0.05 and log2 fold 
change greater than 0.5. Functional gene ontology enrichment analyses 
of significantly differentially expressed genes in HD and DM1 LCLs 
were performed using the DAVID tool (v 6.8) (57, 58), and all of the 
expressed genes in HD and DM1, respectively, were used as the 
background.
Targeted locus amplification
Targeted locus amplification (TLA) was performed on the basis of a 
previously described protocol (34). For each sample, 107 cells were 
cross-linked in 2% formaldehyde for 10 min at room temperature and 
quenched with glycine to a final concentration of 275 mM. Cell were 
lysed for 5 min at room temperature in lysis buffer [50 mM tris-HCl 
(pH 7.5), 150 mM NaCl, 5 mM EDTA, 0.5% NP-40, 1% Triton X-100, 
and 1× protease inhibitors). Cross-linked samples were digested at 
37°C overnight with 400 U of Nla III (New England Biolabs) followed 
by Nla III heat inactivation. Samples were ligated at room temperature 
for 2 hours with 20 U of T4 DNA ligase (Thermo Fisher Scientific) 
in 500 l. Ligated samples were decross-linked with 5-l Proteinase K 
(10 mg/ml) at 65°C overnight, followed by RNAse A treatment and 
phenol- chloroform purification. Samples then digested overnight 
at 37°C with 50 U of Nsp I (New England Biolabs) followed by Nsp I in-
activation. The second ligation was performed overnight at 16°C with 
100 U of T4 DNA ligase in 14 ml. The resulting TLA circularized tem-
plates were purified with the QIAquick PCR Purification Kit. TLA li-
braries were generated by amplifying 800 ng of purified TLA template 
with TLA viewpoint primers (table S5). Paired-end sequencing 
(2 × 150 bp) of pooled TLA libraries was performed on Illumina 
HiSeq 4000. Demultiplexed reads were mapped using a custom TLA 
analysis pipeline using the Burrows-Wheeler Aligner mapping soft-
ware (v 0.7.17) (59). First, reads were mapped to the human genome 
GRCh38. Then, unaligned sequences were digested in silico with the 
Nla III restriction site and remapped to the genome. The combined 
mapping results were used to determine the integration site.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/27/eaaz4012/DC1
View/request a protocol for this paper from Bio-protocol.
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